Pharma companies large and small have found that a small amount of solid-state work can both accelerate and strengthen your development program, as well as your IP. We can make your preclinical formulation development, as well as your API manufacturing, the best it can be.
In addition, baseline screening and understanding will lead to a robust API isolation process that reproducibly gives you the right form, and with the right particle size, at the highest possible yield. The benefits of working with VxP are the following:
- We are a One-stop shop utilizing solid-state and biopharmaceutical properties in design from candidate selection through early development
- We utilize an Integrated approach to find the right form and formulation
- We offer the shortest timeline for appropriate development milestones
- We provide you with an optimized route to achieve exposure, eliminate unnecessary experiments and enable pre-clinical studies